Showing results (1191-1200 of 1,519) with videos related to

Sort By:
Pageof 152
Brain : a Journal of Neurology|September 11, 2019
PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injuryKeisuke Takahata, Yasuyuki Kimura, Naruhiko Sahara, et al.
Stroke|October 7, 2022
Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel DiseaseApoorva A Kumar, Natalie Yeo, Max Whittaker, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2019
X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct DementiaPatrick R Blackburn, Wen-Lang Lin, David A Miller, et al.
Acta Neuropathologica Communications|December 9, 2017
Clinical and neuropathological features of ALS/FTD with TIA1 mutationsVeronica Hirsch-Reinshagen, Cyril Pottier, Alexandra M Nicholson, et al.
Brain Pathology (Zurich, Switzerland)|August 17, 2016
FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372GPawel Tacik, Michael A DeTure, Yari Carlomagno, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissueAnnalise Schweickart, Richa Batra, Kevin Huynh, et al.
Neurology|September 6, 2019
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotensionJay A van Gerpen, Rana Hanna Al-Shaikh, Philip W Tipton, et al.
Brain Communications|June 23, 2020
18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodiesJonathan Graff-Radford, Timothy G Lesnick, Rodolfo Savica, et al.
Neurosurgery Practice|February 17, 2025
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Neurosurgery Practice|March 11, 2024
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Pageof 152